DaVita Inc. (NYSE:DVA) Shares Purchased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its stake in shares of DaVita Inc. (NYSE:DVA) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,255 shares of the company’s stock after purchasing an additional 4,048 shares during the quarter. Envestnet Asset Management Inc. owned about 0.07% of DaVita worth $8,452,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DVA. Epoch Investment Partners Inc. bought a new stake in shares of DaVita in the 4th quarter valued at approximately $55,100,000. Invesco Ltd. raised its stake in shares of DaVita by 20.9% in the fourth quarter. Invesco Ltd. now owns 1,589,545 shares of the company’s stock valued at $237,716,000 after purchasing an additional 275,284 shares in the last quarter. Iron Triangle Partners LP acquired a new position in shares of DaVita in the fourth quarter valued at $38,946,000. GAMMA Investing LLC grew its position in DaVita by 14,695.8% in the first quarter. GAMMA Investing LLC now owns 234,809 shares of the company’s stock valued at $35,919,000 after acquiring an additional 233,222 shares during the period. Finally, Bridgewater Associates LP grew its position in DaVita by 298.4% in the fourth quarter. Bridgewater Associates LP now owns 239,970 shares of the company’s stock valued at $35,888,000 after acquiring an additional 179,744 shares during the period. 90.12% of the stock is currently owned by institutional investors.

DaVita Stock Down 1.2%

DVA stock opened at $139.45 on Tuesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.20 and a current ratio of 1.25. The business’s 50 day moving average price is $140.11 and its two-hundred day moving average price is $148.56. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The company has a market capitalization of $10.53 billion, a price-to-earnings ratio of 13.82, a price-to-earnings-growth ratio of 0.97 and a beta of 1.11.

DaVita (NYSE:DVA) last released its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.25. The firm had revenue of $3.22 billion for the quarter, compared to analysts’ expectations of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.26 EPS. As a group, analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently issued reports on DVA. Wall Street Zen upgraded DaVita from a “hold” rating to a “buy” rating in a research report on Friday, April 25th. Truist Financial cut their price objective on DaVita from $170.00 to $164.00 and set a “hold” rating on the stock in a report on Monday, May 19th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $164.50.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.